NDRA实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (22 May 2024 @ 01:21):

Stats
今日成交量	99 379.00
平均成交量	186 909
市值	3.36M
EPS	$0 ( 2024-05-14 )
下一个收益日期	( $-0.270 ) 2024-08-12
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.340
ATR14	$0.00400 (1.31%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-02	Basenese Lou	Buy	600	Stock Options
2024-01-02	Harsh Michael	Buy	600	Stock Options
2024-01-02	Digiandomenico Anthony	Buy	600	Stock Options
2024-01-02	Tokman Alexander Y	Buy	600	Stock Options
2023-05-18	Thornton Michael Milos	Buy	15 000	Common Stock

INSIDER POWER
100.00
Last 100 transactions
Buy: 3 706 167 \| Sell: 432 712

音量相关性

長: -0.25 (neutral)

短: 0.22 (neutral)

Signal:(52.365) Neutral

ENDRA Life Sciences Inc 相关性

10 最正相关
JWEL	0.943
LULU	0.93
SHC	0.923
EZGO	0.921
GOCO	0.916
IMRX	0.916
DCFC	0.915
AZ	0.915
DXLG	0.915
ASPS	0.913

10 最负相关
KEQU	-0.944
EML	-0.93
IVCB	-0.929
SWAV	-0.929
FUSN	-0.927
CDXC	-0.907
LABP	-0.907
PESI	-0.905
BCSA	-0.904
IMPPP	-0.904

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

ENDRA Life Sciences Inc 相关性 - 货币/商品

-0.03
( neutral )

-0.12
( neutral )

0.00
( neutral )

0.16
( neutral )

ENDRA Life Sciences Inc 财务报表

Annual	2023
营收:	$0
毛利润:	$-275 451 (0.00 %)
EPS:	$-1.580

FY	2023
营收:	$0
毛利润:	$-275 451 (0.00 %)
EPS:	$-1.580

FY	2022
营收:	$0
毛利润:	$-234 258 (0.00 %)
EPS:	$-4.57

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-11.83

Financial Reports:

No articles found.

ENDRA Life Sciences Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

ENDRA Life Sciences Inc

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.